Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Elexacaftor/Tezacaftor/Ivacaftor on P2X7R as Inflammatory Marker and Clinical Outcomes in Patients With Cystic Fibrosis

NCT07841353 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT07841353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07841353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Elexacaftor/Tezacaftor/Ivacaftor on P2X7R as Inflammatory Marker and Clinical Outcomes in Patients With Cystic Fibrosis
Lead sponsor
Ain Shams University
Phase
Observational
Overall status
Completed
Start date
July 25, 2025
Completion date
August 31, 2026
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis (cf)